✦ LIBER ✦

S-1 plus CIK as second-line treatment for advanced pancreatic cancer

✍ Scribed by Wang, Meng; Shi, Sheng-bin; Qi, Jie-lin; Tang, Xiao-yong; Tian, Jing

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan monotherapy as second-line tr

✍ Seong Yoon Yi; Young Suk Park; Hyo Song Kim; Hyun Jung Jun; Kyoung Ha Kim; Myung 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 218 KB

Three-weekly S-1 plus cisplatin chemothe

✍ In Sil Choi; Keun-Wook Lee; Ki Hwan Kim; Yu Jung Kim; Jee Hyun Kim; Jong Seok Le 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 212 KB

Clinical development of S-1 plus cisplat

✍ Wasaburo Koizumi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 171 KB

Phase 2 trial of oxaliplatin plus capeci

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Efficacy of nimotuzumab plus gemcitabine

✍ Su, Dan; Jiao, Shun-Chang; Wang, Li-Jie; Shi, Wei-Wei; Long, Yan-Yan; Li, Juan; 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 161 KB

Oxaliplatin plus irinotecan promising as

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB